Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-05 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.006 |